Nevertheless, the inhibition of Gal-3 with modified citrus pectin, an emerging heart failure therapy for dogs, resulted in the reduced burden of reactive interstitial fibrosis in CHF and reduced and preserved ejection fraction [25]. The gene discussed is LGALS3; the disease is congestive heart failure.